<qa>  What is the name of the STUDY OF CRLX101?A STUDY OF CRLX101 IN COMBINATION WITH WEEKLY PACLITAXEL IN PATIENTS WITH RECURRENT OR PERSISTENT EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER: 